alendronate has been researched along with Injuries, Spinal in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Excerpt | Relevance | Reference |
---|---|---|
"During the second year, the bone resorption marker, serum N-telopeptide, rose by 27% in the calcitriol group (P< or =0." | 2.72 | Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover. ( Addesso, V; Cohen, A; Mancini, D; Maybaum, S; McMahon, DJ; Namerow, P; Shane, E; Staron, RB, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, A | 1 |
Addesso, V | 1 |
McMahon, DJ | 1 |
Staron, RB | 1 |
Namerow, P | 1 |
Maybaum, S | 1 |
Mancini, D | 1 |
Shane, E | 1 |
Lems, WF | 1 |
Dijkmans, BA | 1 |
1 review available for alendronate and Injuries, Spinal
Article | Year |
---|---|
[Effect of anti-osteoporosis agents on the incidence of vertebral fractures].
Topics: Alendronate; Bone Density; Calcitonin; Calcium Channel Blockers; Densitometry; Etidronic Acid; Femal | 2000 |
1 trial available for alendronate and Injuries, Spinal
Article | Year |
---|---|
Discontinuing antiresorptive therapy one year after cardiac transplantation: effect on bone density and bone turnover.
Topics: Adult; Alendronate; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone | 2006 |